Disseminated fungal infections in children infected with human immunodeficiency virus

Pediatric Infectious Disease

Volumn 10, Issue 12, 1991, Pages 888-894

  Leibovitz, Eugene ^a   Rigaud, Mona ^a   Chandwani, Sulachni ^a   Kaul, Aditya ^a   Greco, M Alba ^a   Pollack, Henry ^a   Lawrence, Robert ^a   John, David Di ^a   Hanna, Bruce ^a   Krasinski, Keith ^a   Borkowsky, William ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Children; Disseminated candidiasis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE;

ARTICLE; BRAIN; CANDIDA ALBICANS; CANDIDIASIS; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; DRUG INDUCED DISEASE; ESOPHAGUS; FEMALE; HEART; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LUNG; MALE; MYCOSIS; PRIORITY JOURNAL; THRUSH;

CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMAN; INFANT; MALE; MYCOSES; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 0026317695     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199112000-00002     Document Type: Article

References (47)

1. Edwards JE, Lehrer RI, Stiehm RE, Fisher TJ, Young LS. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 1978;89:91-106.
2. Hawkins C. Armstrong D. Fungal infections in the immunocompromised host. Clin Hematol 1984;13:599-630.
3. Holmberg K, Meyer RD. Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986;18:179-92.
4. Meunier F. Fungal infections in the immunocompromised host. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum, 1988:193-220.
5. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host: changing patterns, ant igenemia, high mortality. Am J Med 1981;71:363-70.
6. Parker JC JR, McCloskey JJ, Lee RS. The emergence of candidosis, the dominant postmortem cerebral mvcosis. Am J Clin Pathol 1978;70:31-6.
7. Hughes W. Systemic candidiasis: a studv of 109 fatal cases. Pediatr Infect Dis J 1982;1:11-8.
8. Maksymiuk AW. Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodev GP. Svstemic candidiasis in cancer patients. Am J Med 1984;77:20-7.
9. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: frequency, earlier onset, and results of therapy. Rev Infect Dis 1985:7:640-55.
10. Reichard CM. O'Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immunodeficiency syndrome. Am J Pathol 1983;112:357-82.
11. Welch K, Finkbeiner W, Alpers C, Blumenfeld W, Davis RL, Smuckler EA, et al. Autopsy findings in the acquired immuno-deficiencv svndrome. JAMA 1984;252:1152-9.
12. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
13. Degregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med 1982:73:543-8.
14. Merz WG. Roberts GD. Detection and recovery of fungi from clinical specimens. In: Ballows A. ed. Manual of clinical microbiology. 5th ed. Washington. DC: American Society for Microbiology, 1991:588-600.
15. Warren NG, Shadomy HJ. Yeasts of medical importance. In: Ballows A. ed. Manual of clinical microbiology. 5th ed. Washington. DC: American Society for Microbiology. 1991.
16. Krasinski KM. Borkowsky W. Bonk S. Lawrence R. Chandwani S. Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1988;7:323-8.
17. Borkowski W. Steele CJ. Grubman S. Moore T, La Russa P, Krasinski K. Antibody responses to bacterial toxoid in children infected with human immunodeficiency virus. J Pediatr 1987;110:563-6.
18. Leibovitz E, Rigaud M, Pollack H. Lawrence R, Chandwani S, Krasinski K, et al. Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lvmphocvtes per cubic millimeter. N Engl J Med 1990;323:531-3.
19. Denny TN, Niven P, Skuza C, Chadwick EG, Kriger L, Amer M, et al. Age related changes of lymphocyte phenotypes in healthy children (Abstract). Pediatr Res 1990;27:155A.
20. Rogers TJ, Balish E. Immunity to Candida albicans. Microbiol Rev 1980;44:660-82.
21. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert KM, Gutman L, et al. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am J Med 1981;71:59-66.
22. Wilson BD, Sohnle PG. Participation of neutrophils and delayed hypersensitivity in the clearance of experimental cutaneous candidiasis in mice. Am J Pathol 1986;123:241-9.
23. Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988;35:543-63.
24. Fauci AC, Lane HC. The acquired immunodeficiency syndrome (AIDS): an update. Int Arch Allergy Appi Immunol 1985;77:81-8.
25. Smith PS, Ohura K, Masur H, Lane HC, Fauci AS, Wahl SM. Monocyte function in the acquired immunodeficiency syndrome: defect Chemotaxis. J Clin Invest 1984;74:2121-8.
26. Kotler DP, Scholes JV. Altered intestinal plasma cells in AIDS [Abstract M-14]. Washington, DC: International Conference on Aids, 1985.
27. Mourad S, Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia 1968;6:103-5.
28. Gelfand JA, Hurley DL, Fauci AS, Frank MM. Role of complement in host defense against experimental disseminated candidiasis. J Infect Dis 1978;138:9-16.
29. Kozel TR, Brown RR, Pfrommer GS. Activation and binding of C3 by Candida albicans. Infect Immun 1987;55:1890-4.
30. Rotrosen D, Calderone RA, Edwards JE. Jr. Adherence ot Candida species to host tissue and plastic surfaces. Rev Infect Dis 1986;8:73-85.
31. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andre-mont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988;26:429-32.
32. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989;18:554-64.
33. Körting HC, Ollert M, Georgii A, Froschl M. In citro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiencv virus. J Clin Microbiol 1989;26:2626-31.
34. Tavitian A, Raufman JP, Rosenthal LE. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:54-5.
35. DeGregorio MW, Lee WMF, Ries CA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982;50:2780-4.
36. Hansen RM, Reinerio N, Sohnle PG, Abrams RA, Ritch PS, Libnoch JA, et al. Ketoconazole in the prevention of candidiasis in patients with cancer: a prospective, randomized, controlled, double-blind study. Arch Intern Med 1987;147:710-12.
37. Meunier F. Prevention of mycoses in immunocompromised patients. Rev Infect Dis 1987;9:408-16.
38. Walsh TJ, Butler KM. Fungal infections complicating pediatric AIDS. In: Pizzo PA, Wilfert CA, eds. Pediatric AIDS: the challenge of HIV infection in infants, children and adolescents. Baltimore: Williams & Wilkins, 1991:225-44.
39. Medoff G. Dismukes WE. Meade RH III. Moses JM. A new therapeutic approach to Candida intections: a preliminary report. Arch Intern Med 1972;130:241-5.
40. Samonis G, Rolston K, Karl C, Miller P, Bodey GP. Prophylaxis of oropharyngeal candidiasis with fluconazole. Rev Infect Dis 1990;12:S369-73.
41. De Wit S, Weerts D, Goosens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;1:746-7.
42. Sandford GR, Merz WG, Wingard JR, Charache P, Sarai R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980;142:503-9.
43. Armstrong D. Problems in management of opportunistic fungal diseases. Rev Infect Dis 1989;ll:Sl591-9.
44. Bennett JE. Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 1987;9:398-402.
45. Gallis HA, Drew RA, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
46. Walsh TJ, Lee J, Aoki S, Mechinaud F, Bacher J, Lecciones J, et al. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Rev Infect Dis 1990;12:S307-17.
47. Robinson PA, Knirsch AK, Joseph JA. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Rev Infect Dis 1990; 12:S349-63.